Drug Type Universal CAR-T |
Synonyms EGFR IL12 CART |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), IL-12 modulators(Interleukin-12 modulators), Gene transference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Phase 1 | CN | 22 May 2018 |